XML 25 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders Equity (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of fair value options granted

   2019   2018 
         
Underlying value of ordinary share ($)   1.7-10    1.7-2 
Exercise price ($)   1.7-10    1.7-2 
Expected volatility (%)   93.1    93.1 
Term of the option (years)   6.25    6.25 
Risk-free interest rate (%)   2.23    2.25-3.05 
Schedule of options to purchase company's ordinary shares

   For year ended December 31, 
   2019 
   Employees   Consultants 
   Number of
Options
   Weighted
average
exercise
price
   Aggregate
intrinsic
value
   Number of
Options
   Weighted
average
exercise
price
   Aggregate
intrinsic
value
 
                         
Outstanding at the beginning of year   1,868,749    1.58    849    702,388    0.69    944 
Granted   704,699    2.03         79,630    2.03      
Forfeited   (137,682)   1.90         -           
Exercised   (74,581)   1.34         -           
Outstanding at the end of year   2,361,185    1.87    19,185    782,018    0.82    6,588 
Vested at year end   1,011,862              470,236           
Weighted average remaining contractual life – years as of December 31, 2019   8.16              7.29           

 

   For year ended December 31, 
   2018 
   Employees   Consultants 
   Number of
Options
   Weighted
average
exercise
price
   Aggregate
intrinsic
value
   Number of
Options
   Weighted
average
exercise
price
   Aggregate
intrinsic
value
 
                         
Outstanding at the beginning of year   1,278,900    1.29    840    518,442    0.21    915 
Granted   801,310    1.98         183,946    2.03      
Forfeited   (180,523)   1.63         -           
Exercised   (30,938)   (*)         -           
Outstanding at the end of year   1,868,749    1.58    849    702,388    0.69    944 
Vested at year end   653,201              323,111           
Weighted average remaining contractual life – years as of December 31, 2018   8.65              8.1           

 

(*)Less than $0.01.
Schedule of share-based payment expenses

   Year ended
December 31,
 
   2019   2018 
   USD In thousands 
         
R&D   450    623 
General and administrative   488    328 
    938    951 
Schedule of outstanding warrants

Warrant   Issuance Date   Expiration Date   Exercise Price
Per Share
    Number of
Shares of
Common Stock
Underlying
Warrants
 
Private Warrants issued to Yeda(see 1 below)   May 11, 2017   May 11, 2025     (*)       591,382  
Private Warrants issued to Founders (see 2 below)   November 27, 2017         -       10,589  
Private Placement Warrants (see 3 below)  

IPO

(December 13, 2018)

  December 13, 2023   $ 11.50       2,900,000  
Public Warrants (see 4 below)  

IPO

(December 13, 2018)

  October 28, 2024   $ 11.50       3,500,000  
                      7,001,971  

 

  (*) less than $0.001.